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Of the various sphingolipid metabolites, including sphin-
gosine, sphingosylphosphorylcholine (SPC), dimethyl-
sphingosine, sphingosine-1-phosphate, N-acetylsphingo-
sine, and skin-specific ceramides, only SPC accelerated
cutaneous wound healing in full-thickness excision
wounds in genetically healing-impaired diabetic (db/db)
mice. A histologic examination revealed that SPC pro-
moted not only granulation tissue formation, but also the
re-epithelization of epidermal keratinocytes. As the direct
effects of SPC on keratinocytes are completely unknown,
we investigated the effects of SPC on normal cultured
human keratinocytes. SPC concentration-dependently
enhancedDNAsynthesis in keratinocytes,with an increase
in intracellular calcium concentrations due to the release
of calcium ions from intracellular stores. SPC upregulated
The N-deacyl derivatives of sphingolipids, such as sphingo-sine, sphingosine-1-phosphate, and sphingosylphosphor-ylcholine (SPC), are generally mitogenic (Spiegel andMilstien, 1995) and are candidates for evaluation inwound healing. This is in contrast to the N-acylated
forms of sphingolipids such as ceramide, which has anti-proliferative
and apoptosis-inducing properties (Hannun, 1996). In fact, Sun et al
(1996) recently demonstrated that SPC accelerated the healing of
cutaneous wounds in genetically healing-impaired diabetic (db/db)
mice. They showed that SPC increased the number of BrdU-labeled
cells in both dermal and epithelial compartments at the wound sites of
diabetic mice, and stimulated DNA synthesis in cultured cells, including
3T3 fibroblasts, primary endothelial cells, and virally transformed
endothelial cells. The direct effect of SPC on keratinocytes, however,
was not apparent in their study. In addition, it is not known whether
other lyso forms of sphingolipid metabolites have such an effect.
In the re-epithelization process during cutaneous wound healing,
the migration of keratinocytes is a crucial step, in which limited
proteolysis of the surrounding extracellular matrix is required. In
general, plasminogen activator (PA) participates in cell migration
Manuscript received June 25, 1997; revised October 7, 1997; accepted for
publication November 7, 1997.
Reprint requests to: Dr. Hisashi Wakita, Department of Dermatology,
Hamamatsu University School of Medicine, 3600 Handa-cho, Hamamatsu
431–31, Japan.
Abbreviations: PA, plasminogen activator; SPC, sphingosylphosphorylcholine;
uPA, urokinase-type plasminogen activator; uPA-R, urokinase-type plasminogen
activator receptor.
0022-202X/98/$10.50 · Copyright © 1998 by The Society for Investigative Dermatology, Inc.
253
cell surface plasminogen activity, and at the same time
increased the cell surface expression of urokinase-type
plasminogen activator (uPA) and urokinase-type plasmin-
ogen activator-receptor (uPA-R) in keratinocytes. Fur-
thermore, SPC promoted the in vitro wound repair of
cultured keratinocytes, which was partially blocked by an
anti-uPA monoclonal antibody. Our results suggest that
one of the mechanisms responsible for the SPC-mediated
promotion of cutaneous wound healing seems to be an
enhancement of re-epithelization caused by the direct
stimulation of the proliferation of keratinocytes, and an
activation of the uPA/uPA-R system, which enhances the
migration of keratinocytes. Key words: sphingolipid/urokin-
ase/urokinase receptor. J Invest Dermatol 110:253–258, 1998
processes, such as endothelial cell migration during angiogenesis (Pepper
and Montesano, 1990; van Hinsbergh et al, 1997) and tumor cell
migration (Ossowski, 1996). The involvement of the plasminogen
activator system has also been proposed in the keratinocyte migration
process (Kramer et al, 1995). In particular, cell surface-associated
plasminogen activation by epidermal keratinocytes is thought to play
a crucial role in re-epithelization during cutaneous wound healing.
Urokinase-type plasminogen activator (uPA) is bound to the uPA
receptor (uPA-R) on the cell surface of keratinocytes, and activates
plasminogen, which in turn breaks the migration path by pericellular
proteolysis. This proposition is supported by several facts, such as the
presence of uPA in the keratinocytes at the edge of the wounds both
in vivo (Grondahl-Hansen et al, 1988) and in vitro (Morioka et al, 1987)
and the strong expression of uPA-R in migrating keratinocytes (McNeill
and Jensen, 1990).
In this study, we found that among several sphingolipid derivatives,
only SPC was effective in cutaneous wound healing in diabetic mice.
The effect of SPC could be mediated by a promotion of proliferation
and an upregulation of the expression of uPA and uPA-R, which are
both demonstrated in keratinocyte cultures.
MATERIALS AND METHODS
Chemicals Sphingosine, N,N-dimethylsphingosine, sphingosine-1-phos-
phate, and SPC were purchased from Sigma (St. Louis, MO). Skin-specific
ceramides including N-(27-stearoyloxy-heptacosanoyl)-phytosphingosine (cera-
mide I), N-stearoyl-phytosphingosine (ceramide III), N-oleoyl-phytosphingos-
ine (ceramide IIIB), and N-2-hydroxystearoyl-phytosphingosine (ceramide VI)
were donated by Dr. H. Lambers (Gist-Brocades, Delft, the Netherlands). N-
acetyl-sphingosine (C2-ceramide) was prepared by N-acylation of D-erythros-
phingosine using anhydrous acetic acid (molar ratio 1:10) as previously described
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Figure 1. SPC promotes wound healing in diabetic mice. Various
sphingolipid metabolites, including sphingosine (SPH), SPC, N,N-
dimethylsphingosine (DMS), sphingosine-1-phosphate (S1P), N-acetyl-
sphingosine (C2-Cer), skin-specific ceramides (Cer I, Cer III, Cer IIIB, or Cer
VI) (a), and various concentrations of SPC (b) were applied to the wound. The
size of the wound area was then assessed 14 d after wounding. The size of the
granulation tissue (c) and the length of the non-re-epithelized surface (d) were
also analyzed microscopically at 14 d after wounding. The data represent the
mean 6 SD from one representative experiment (n 5 5). Identical results were
obtained in two other independent experiments. *Significantly different from
control (p , 0.05).
(Gaver and Sweeley, 1966). The purity of the sphingolipids was over 95%,
and was verified by thin layer chromatography or high performance liquid
chromoatography analysis (Wakita et al, 1992). The sphingolipids, except for
the skin-specific ceramides, were dissolved in absolute ethanol (100 mM). They
were conjugated to 2 mM fatty acid-free bovine serum albumin (Boehringer,
Indianapolis, IN) (Merrill et al, 1989) from stock solutions of sphingolipid-
albumin complex at a molar ration of 1:1. The ceramides were dispersed in a
solvent mixture of ethanol and dodecane (Ji et al, 1995). All other reagents,
unless otherwise noted, were purchased from Sigma.
Animals Genetically healing impaired diabetic female mice (db/db), based on
a C57BL/KsJ phenotypic background, were purchased from CLEA (Tokyo,
Japan). They exhibited characteristics similar to those of human adult-onset
diabetes as a result of a single autosomal recessive mutation on chromosome 4.
Only the homozygous animals developed diabetes (Coleman, 1982). The
animals were 8 wk of age at the start of the experiments. The animals were
housed one per cage, and were maintained in a central animal facility with a
12 h light/dark cycle.
Wound area measurement A single, full-thickness, 6-mm diameter
excisional wound was made with a sterile biopsy punch on the mid-dorsum of
each db/db mouse according to the previously described method (Sun et al,
1996), and the wounds were dressed with a transparent film (Bioclusive, Johnson
& Johnson, Arlington, TX). In each experiment, groups of five mice were
treated with various concentrations of each bovine serum albumin-conjugated
lipids in phosphate-buffered saline (PBS: 10 mM sodium phosphate, 133 mM
sodium chloride, pH 7.4), or bovine serum albumin/PBS vehicle (as control).
The wounds were treated with 10 µl per dose of either lipids or bovine serum
albumin applied topically once daily for 14 consecutive days after the injury.
The wound areas were traced on a transparent plastic film with a marker pen
1 h after wounding (day 0) and again on day 14. The wound areas traced on
the plastic film were then measured with a computer-assisted image analyzer
(NIH Image software for Macintosh). Areas 10 mm in diameter that completely
included the epithelial margins were then excised on day 14. The wound tissues
were fixed in 10% formamide, processed, and paraffin embedded. Sections were
cut perpendicular to the longitudinal direction of the wounds, and were stained
with hematoxylin and eosin for light microscopic analysis. The wounds were
photographed for analyzing the length of the non-re-epithelized surface and
the size of the granulation tissue with the NIH Image software.
Cell culture Normal human keratinocytes derived from foreskins (Epipack,
Clonetics, San Diego, CA) were grown in serum-free, keratinocyte-growth
medium (Clonetics) supplemented with 10 ng epidermal growth factor per ml
and 60 ng whole bovine pituitary extract per ml in a humidified incubator
with 5% CO2 in air at 37°C. Cells at more than 90% confluency were re-
cultured in KBM without epidermal growth factor or whole bovine pituitary
extract, and were then incubated for another 48 h. The quiescent cells were
then treated with SPC in fresh KBM for varying periods of time.
Assay for DNA synthesis The keratinocytes were seeded at a density of
1 3 104 cells per well into 96 well plates in keratinocyte-growth medium.
Forty-eight hours after seeding, the cells were re-fed with KBM and incubated
for another 48 h. The cells were then exposed to various concentrations of
SPC in fresh KBM for 24 h, and incubated with 1 µCi [methyl-3H]thymidine
for another 12 h. The adherent cells were detached with ethylenediamine
tetraacetic acid/trypsin, and were collected on a glass filter, and the radioactivity
was measured by scintillation counting.
Measurement of intracellular calcium concentration The intracellular
free calcium concentration ([Ca21]i) was analyzed as previously described
(Wakita et al, 1995). In brief, keratinocytes cultured in Lab-Tek chambered
cover glasses (Nunc) were incubated with 5 µM of the acetoxymethylester of
Fura-2 (Dojin Laboratories, Kumamoto, Japan) in phenyl red-free KBM in the
dark for 1 h at room temperature. Following extensive washing, SPC was
added to the cells in the same medium. Fluorescence images were then obtained
at alternating excitation wavelengths of 340 and 380 nm through a SIT video
camera, and were processed with a digital image processing system, the Argus-
100/CA designed by Hamamatsu Photonics (Hamamatsu, Japan). Calibration
of the fluorescence signals in terms of the [Ca21]i was performed as previously
described (Seishima et al, 1993).
Measurement of cell surface PA activity Cell surface PA activity was
measured according to the method of Osada et al (1991). In brief, confluent
and quiescent keratinocytes in 96 well plates were exposed to SPC in the
presence or absence of 100 µg neutralizing antibodies per ml against uPA
[mouse monoclonal antibody (#394, American Diagnostica, Greenwich, CT)
or a goat anti-uPA immunoglobulin (Biopool, Umea, Sweden)] for 24 h. The
cells were then washed with Hank’s balanced salt solution (Gibco, Grand Island,
NY) and incubated at 37°C in 200 µl of Hank’s balanced salt solution containing
0.2 mM of a chromogenic substrate, S-2251 (KabiVitrum, Stockholm, Sweden),
and 20 µg lys-plasminogen per ml (provided by Dr. T. Urano, Department of
Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan).
The difference in absorbance between 405 nm and 630 nm in each well was
directly measured at 90 min and 120 min after the addition of S-2251 and
plasminogen using a microplate reader, and the slopes between 90 min and
120 min were plotted as the cell surface PA activity.
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Figure 2. SPC stimulates DNA synthesis in cultured human
keratinocytes. Various concentrations of SPC were added to confluent
and quiescent cultures of human keratinocytes, and [methyl-3H]thymidine
incorporation was measured as described in Materials and Methods. The data
represent the mean 6 SD from one representative experiment performed in
triplicate. Identical results were obtained in two other independent experiments.
Flow cytometry Single-cell suspensions were prepared by treating the
cultured cells with 0.25% trypsin and 1 mM of ethylenediamine tetraacetic acid
in PBS. After washing with PBS, 105 cells were incubated with 5 µl of
anti-uPA (#394) or anti-uPA-R (#3936, American Diagnostica) monoclonal
antibody, or with a control antibody of the same isotype for 30 min on ice.
The cells were then treated with a fluorescein isothiocyanate-conjugated affinity
purified goat antibody directed against the mouse IgG F(ab9)2 (1:50 dilution,
Cappel, Cochraville, PA) for 30 min at 4°C. After washing with PBS, the
immunostained cells (dead cells were excluded by propidium iodide staining)
were analyzed in a FACScan flow cytometer (Becton Dickinson, Mountain
View, CA). The mean fluorescence intensity on the abscissa was expressed as a
logarithmic scale. The mean fluorescence intensity values in the results were
obtained by subtracting the control mean fluorescence intensity values.
In vitro wound-healing assay The wound-healing assay of the cultured
keratinocytes was performed according to commonly used methods (Kherad-
mand et al, 1994; Quax et al, 1994). The cells were grown to confluency in
35 mm tissue culture dishes. A mechanically wounded rectangular area about
15 mm2 was made through the confluent monolayer of cells with a scraper.
After wounding, the cultures were washed twice with PBS to remove the
detached cells. Subsequently, the cultures were incubated at 37°C with fresh
media to which either no additives (control) or various concentrations of SPC
were added. Refilling of the wounded area with migrating cells was followed
by means of phase contrast microscopy over a period of 4 d, and was
photographed. The progress of cells moving into the wound area was calculated
by measuring the size of photographed wounds with the computer-associated
NIH imager analyzer as described above.
Statistical analysis Data from triplicate experiments were analyzed with
Student’s t test. Two other independent experiments were performed and gave
identical results. A p value , 0.05 was considered to be statistically significant.
RESULTS
SPC but not other sphingolipid metabolites promotes cutaneous
wound healing in an in vivo mouse model The initial experiments
evaluated the ability of various sphingolipid derivatives to promote
in vivo excisional wound healing in the skin of five db/db mice.
Immediately after surgery various sphingolipid derivatives were applied
once daily for 14 d. The wound was traced on the plastic film on the
day of surgery (day 0), and again on day 14 for measuring the size of
the wound by computer-assisted morphometry. In confirmation of the
study by Sun et al (1996), SPC treatment induced a statistically
significant promotion of wound healing (Fig 1a; p , 0.05). In contrast,
although sphingosine and sphingosine-1-phosphate had a tendency to
promote wound healing, sphingolipid derivatives other than SPC
showed no statistically significant difference from the control. In
Figure 3. SPC increases [Ca21]i in cultured keratinocytes. (a) At the
indicated time (→), 2 µM SPC was added to Fura-2/AM-labeled keratinocytes
incubated in KBM (Ca21 at 0.1 mM). The change in the [Ca21]i was
determined as described in Materials and Methods. The [Ca21]i of five responsive
cells is shown. (b) The basal and SPC-induced mean peak values of [Ca21]i
were compared between cells in KBM [Ca21(1)] and cells in PBS containing
5 mM ethylene glycol-bis (β-aminoethyl ether) tetraacetic acid [Ca21(–)]. The
data represent the mean 6 SD from one representative experiment (n 5 10).
Identical results were obtained in two other independent experiments.
addition, various concentrations (1 nM, 10 nM, 100 nM, 1 µM,
10 µM, and 50 µM) of sphingosine, sphingosine-1-phosphate, or C2-
ceramide did not show significant promotion of wound healing. By
applying a wide concentration range of SPC (0.01–50 µM), it was
found that the optimum concentration of SPC was around 2 µM, as
shown in Fig 1(b). The effects of SPC on wound healing were further
analyzed microscopically with the sections obtained on day 14. The
size of the granulation tissue, which was mainly composed of fibroblasts
and endothelial cells, had increased and the length of the non-re-
epithelized surface had decreased significantly following SPC treatment
as compared with the control. Neither sphingosine nor C2-ceramide
showed these effects (Fig 1c, d).
SPC stimulates DNA synthesis in normal quiescent
keratinocytes SPC stimulated DNA synthesis in normal quiescent
human keratinocytes cultured in growth factor-depleted medium
(KBM), as measured by [methyl-3H]thymidine incorporation (Fig 2).
A mitogenic effect was observed at concentrations of SPC as low as
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Figure 4. SPC induces a wave of [Ca21]i spreading over the entire cell.
Pseudocolor images of the Fura-2 fluorescence intensity ratio imaging were
obtained in keratinocytes stimulated with 2 µM SPC. The [Ca21]i was visualized
by dual fluorescent microscopy (340 nm/380 nm ratio image) as described in
Materials and Methods. The color scale depicts a pixel intensity for [Ca21]i from
70 nM to 420 nM.
250 nM, and a maximum stimulation of 3-fold was achieved at 2 µM.
Up to this concentration, there was no loss of cell viability; over 95%
of the cells were viable. At concentrations higher than 5 µM,
SPC inhibited [3H]thymidine incorporation due to cytotoxicity, as
determined by Trypan blue dye exclusion.
SPC increases intracellular calcium concentrations We exam-
ined the effects of SPC on the mobilization of intracellular calcium in
keratinocytes. Agonist-induced calcium mobilization differs between
keratinocytes in suspension and those grown as a monolayer on cover
glasses (Tuschil et al, 1992). Therefore, we monitored the intracellular
calcium concentrations in keratinocytes grown on cover glasses by
using digital imaging fluorescence microscopy. The addition of phenyl
red-free KBM containing 0.1 mM Ca21 alone did not increase the
[Ca21]i during a 15 min incubation (data not shown). When 2 µM
SPC (which is a mitogenic concentration of SPC) was added, the
[Ca21]i content increased rapidly, peaking at 45 s and then gradually
returning to basal levels by 165 s (Fig 3a). This wave of [Ca21]i was
observed in over 80% of the individual cells, and was usually spread
over the entire cell (Fig 4) The treatment of the keratinocytes in
calcium-free PBS containing 5 mM ethylene glycol-bis (β-aminoethyl
ether) tetraacetic acid with 2 µM SPC in calcium-free PBS, induced
the identical [Ca21]i mobilization pattern to that seen in Ca
21-
containing medium, in terms of the rate of onset and the magnitude
(Fig 3b), although the basal [Ca21]i levels were slightly lower in the
absence of Ca21. These results suggest that SPC increases the [Ca21]i
by mobilizing calcium from intracellular pools.
SPC induces cell surface PA activity on keratinocytes When
quiescent keratinocytes were incubated with various concentrations of
SPC for 24 h, cell surface PA activity was significantly upregulated by
concentrations of SPC between 0.5 and 5 µM (Fig 5a). The effects
were dose dependent with a maximal effect at 2 µM SPC.
The increase in cell surface PA activity mediated by SPC was almost
completely inhibited by a neutralizing anti-uPA monoclonal antibody,
suggesting that the cell surface PA activity was predominantly derived
from uPA bound to the uPA-R. In contrast, indomethacin could not
abolish the effect of SPC (Fig 5b).
SPC upregulates the cell surface expression of uPA and uPA-R
on keratinocytes The increase in cell surface PA activity mediated
Figure 5. SPC upregulates cell surface PA activity in keratinocytes.
Keratinocytes were incubated with graded concentrations of SPC (0.5–10 µM)
(a) or 2 µM SPC in the presence or absence of 3 µM indomethacin, mouse
anti-uPA monoclonal antibody, or goat anti-uPA immunoglobulin (b) for 24 h.
Cell surface PA activity was then measured as described in Materials and Methods.
The data represent the mean 6 SD from one representative experiment
performed in triplicate. Identical results were obtained in two other independent
experiments.
by SPC suggests that SPC upregulates the expression of uPA and uPA-
R on keratinocyte cell surfaces. Therefore, we next analyzed the cell
surface expression of uPA and uPA-R by flow cytometry with anti-
uPA and anti-uPA-R antibodies, respectively, in single cells obtained
24 h after SPC stimulation. The log-mean fluorescence intensity of
both uPA and uPA-R was upregulated by SPC treatment in a dose-
dependent manner up to 5 µM (Fig 6a, b).
SPC enhances the in vitro wound repair of keratinocytes Finally,
to obtain direct evidence that SPC has the ability to enhance the re-
epithelization of keratinocytes, we assessed the effects of SPC on in vitro
wound repair of cultured keratinocytes. For this purpose, confluent
monolayers of keratinocytes were scraped to form a clear pathway, and
the cultures were maintained over the next 4 d to assess the effects of
SPC on the ability of keratinocytes to fill the denuded areas by
monitoring their size. This experiment was repeated three times. Re-
population of the denuded area is possible due to cell migration and/
or cell proliferation.
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Figure 6. SPC upregulates cell surface-associated uPA and uPA-R
expression in keratinocytes. Keratinocytes were exposed to graded
concentrations of SPC (0.1–5 µM) for 24 h. The cells were then analyzed for
uPA (a) and uPA-R (b) expression by flow cytometry as described in Materials
and Methods. The data represent the mean 6 SD of one representative
experiment performed in triplicate. Identical results were obtained in two other
independent experiments. *Significantly different from control (p , 0.05 or less).
As shown in Fig 7(a, b), a statistically significant reduction in the
size of the denuded area was observed in cultures containing 2 µM
SPC, as compared with the medium only cultures at 2 d after wounding.
Cultures with 0.5 or 5 µM SPC had a tendency to reduce the denuded
areas, but no statistically significant difference from the control was
observed. At 4 d after scraping, both 2 and 0.5 µM SPC enhanced the
wound repair, without any significant effects at 5 µM.
To elucidate the mechanism of the wound repair-enhancing ability
of SPC, an anti-uPA antibody was simultaneously added with the SPC
(Fig 7b). The effects of SPC were partially but not completely inhibited
by the anti-uPA antibody, suggesting that the wound repair-enhancing
ability of SPC was dependent not only on upregulating uPA activity,
but also on stimulating the proliferation of keratinocytes.
DISCUSSION
Although sphingolipids such as sphingosine and sphingosine-1-phos-
phate have mitogenic effects on quiescent Swiss 3T3 fibroblasts (Zhang
Figure 7. SPC promotes the in vitro wound repair of cultured human
keratinocytes. Cultured keratinocytes were denuded with a scraper, and were
then incubated with various concentrations of SPC (a) or 2 µM SPC in the
presence or absence of an anti-uPA monoclonal antibody (b). The effects of
SPC on wound closure were quantitated at days 2 and 4 (a) or day 4 (b) after
wounding, as described in Materials and Methods. Identical results were obtained
in two other independent experiments. *Significantly different from that of
control at p , 0.05 or less.
et al, 1990, 1991), among the various sphingolipid metabolites examined
in this study, SPC was the only agent that could accelerate cutaneous
wound healing in the diabetic mouse model. This effect of SPC must
be mainly dependent on its mitogenic activity on various cell types in
the skin, because the SPC is the most potent among the various
sphingolipid metabolites in the promotion of cell proliferation (Desai
and Spiegel, 1991; Spiegel and Milstien, 1995); however, it has
not been demonstrated whether SPC is also directly mitogenic in
keratinocytes. Our results showed that SPC alone stimulated DNA
synthesis in human keratinocytes cultured under serum- and growth
factor-free conditions. In addition, SPC mobilized [Ca21]i from
intracellular storage pools. As it has been proposed that the control of
cellular Ca21 by SPC is the basis of its potent mitogenic activity
(Zhang et al, 1991; Desai et al, 1993), this effect of SPC might also
participate in its mitogenic activity on keratinocytes. Theoretically,
SPC could promote re-epithelization in cutaneous wound healing, at
least partially, by enhancing the proliferation of keratinocytes.
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The re-epithelization of cutaneous wounds requires not only the
proliferation, but also the migration of keratinocytes over the exposed
granulation tissues. During this process, cell surface-associated uPA
activity on keratinocytes plays a crucial role in degradating the
surrounding extracellular matrix. In addition, Romer et al (1996)
showed the importance of plasminogen for normal cutaneous wound
healing by using plasminogen-knockout mice. We therefore investi-
gated whether SPC modulates cell surface PA activity in cultured
keratinocytes, as SPC enhanced the re-epithelization of wounds in the
diabetic mouse model (significant reduction in the length of the non-
re-epithelized surface). Our study showed that the cell surface PA
activity on keratinocytes was significantly upregulated by SPC; this
was reversed by a neutralizing anti-uPA antibody. These results suggest
that SPC upregulates cell surface uPA activity. Although SPC stimulates
the release of arachidonic acid from cultured 3T3 fibroblasts (Desai
et al, 1993), and both uPA activity and uPA and uPA-R mRNA levels
were enhanced by prostaglandin E2 in rat calvarial osteoblasts (Allan
and Martin, 1995), indomethacin did not have any effect on the SPC
enhancement, thus precluding the involvement of eicosanoids in
this process.
In contrast to its powerful mitogenic activity, the other biologic
effects of SPC, such as the induction of the cell surface expression
of proteins, have not been studied. Because SPC enhanced cell
surface PA activity in keratinocytes, we investigated whether SPC
could modulate the cell surface expression of uPA and uPA-R.
Flow cytometric analysis showed that SPC upregulated the expression
of both molecules on the cell surface of keratinocytes after incubation
periods similar to those used in the cell surface PA activity assay.
Therefore, SPC enhanced cell surface PA activity by increasing the
number of cell surface-associated uPA molecules bound to the
uPA-R.
The uPA/uPA-R system facilitates the migration of keratinocytes
by activating plasminogen, which degradates fibrin clots and the
extracellular matrix. This system also seems to enhance the migration
of the keratinocytes themselves, because neutralizing antibodies
against u-PA suppressed keratinocyte migration in wounded cultures,
an environment that does not contain migration-disturbing fibrin
clots or extracellular matrix (Quax et al, 1994). In accordance with
the previous results, we showed that SPC directly enhanced wound
repairing in cultured keratinocytes; this was inhibited by a neutralizing
anti-uPA antibody. It is noteworthy that the effects of SPC were
observed under serum-free conditions, which did not contain
significant amounts of plasminogen. In fact, we could not detect
plasminogen in either the culture medium or the cell lysate of
keratinocytes used in this study by a latex aggregation assay with
anti-plasminogen antibody, which detects plasminogen higher than
0.625 µg per ml. Therefore, the plasminogen activator-dependent
migration of keratinocytes might occur independently of plasmin
generation, as has been reported by Del Rosso et al (1990), showing
that the in vitro migration of keratinocytes could be enhanced by
the binding of uPA to the uPA-R under plasminogen-free conditions;
however, plasminogen could bind to several cell surface molecules
such as enolase and gangliosides, and might persist in cell culture
for many days after serum removal (Redlitz and Plow, 1995). Then,
the participation of plasminogen in in vitro keratinocyte migration
could not be completely negligible, because a trace amount of
plasminogen might exist on keratinocytes.
In conclusion, this study demonstrates for the first time the direct
effects of SPC on keratinocytes. These effects include the induction
of cell surface uPA/uPA-R expression as well as the mitogenic
activity of SPC, the only biologic effect of SPC on cultured cells
that has been reported. Both effects could be responsible for the
enhanced cutaneous wound healing mediated by SPC.
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